Childhood Acute Megakaryocytic Leukemia (M7) Unknown Status Phase 3 Trials for Cytarabine (DB00987)

IndicationStatusPhase
DBCOND0028563 (Childhood Acute Megakaryocytic Leukemia (M7))Unknown Status3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00369317Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic SyndromesTreatment